Regenesome

Tokyo, Japan

Regenesome is a biotechnology company that specializes in developing anti-aging technology to solve the problems of aging.

$135K raised

Sep 2025

Pre-Seed

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Regenesome raised?

Regenesome has raised $135K in total funding. The most recent round was Pre-Seed. The last funding was announced in September 2025.

Who are Regenesome's investors?

Regenesome's investors include Leave a Nest Capital, Japan System Techniques.

Where is Regenesome headquartered?

Regenesome is headquartered in Tokyo, Japan.

What does Regenesome do?

Regenesome is a biotechnology company that specializes in developing anti-aging technology to solve the problems of aging.

What stage is Regenesome at?

Regenesome is at the Pre-Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated September 18, 2025.

MLA

"Regenesome — Funding & Investors." VCBacked, September 18, 2025, https://www.vcbacked.co/company/regenesome. Accessed July 3, 2026.

APA

VCBacked. (2025). Regenesome — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/regenesome

Wikipedia (cite web)

{{cite web |title=Regenesome — Funding & Investors |url=https://www.vcbacked.co/company/regenesome |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated September 18, 2025.